# Apolipoprotein E (APOE) Genotype Effects on Triglycerides and Blood Flow in the Human Brain

> **NCT04692441** · NA · RECRUITING · sponsor: **University of Washington** · enrollment: 90 (estimated)

## Conditions studied

- Alzheimer Disease
- Dementia

## Interventions

- **DIETARY_SUPPLEMENT:** Heavy Cream

## Key facts

- **NCT ID:** NCT04692441
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-05-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2024-05-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04692441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04692441, "Apolipoprotein E (APOE) Genotype Effects on Triglycerides and Blood Flow in the Human Brain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04692441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*